Clinical Trial Update: Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML [NA]

View source ↗

Summary

A terminated clinical trial in older adults with previously untreated acute myeloid leukemia evaluating vosaroxin and cytarabine; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Vosaroxin (vosaroxin)

Snippet

Sponsor: Hamid Sayar | Conditions: Leukemia, Myeloid, Acute | NA | Status: TERMINATED | Results posted: 2017-09-20